Activities relating to cardiomyopathy

Not later than 18 months after December 23, 2024, the Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall submit to Congress a report on findings generated from existing activities conducted by the Centers for Disease Control and Prevention to improve the understanding of the prevalence and epidemiology of cardiomyopathy across the lifespan, from birth to adulthood, with particular interest in the following: Subject to paragraph (3), the report submitted under this subsection shall be made available to the public. The Secretary shall ensure that this subsection is carried out in a manner that complies with all applicable privacy laws under Federal and State law. The Secretary shall develop and make publicly available a cardiomyopathy risk assessment for health care providers and individuals. Such risk assessment shall, at a minimum, include the following: In carrying out paragraph (1), the Director of the Centers for Disease Control and Prevention shall seek input from external stakeholders including— In this section, the term “cardiomyopathy” has the meaning given to such term in section 244a of this title.